The largest database of trusted experimental protocols
> Anatomy > Body System > Systems, Nervous

Systems, Nervous

The Nervous System, also known as the Neurological System, is a complex network of specialized cells and tissues that coordinate the actions and sensations of the human body.
It is responsible for processing and transmitting information from the brain and spinal cord to the rest of the body, and vice versa.
The Nervous System is divided into two main parts: the Central Nervous System (CNS), which includes the brain and spinal cord, and the Peripheral Nervous System (PNS), which includes all the nerves that branch out from the CNS.
Together, these components work seamlessly to recieve, process, and respond to internal and external stimuli, enabling essential functions such as movement, sensation, cognition, and emotion.
Undertsanding the intricate workings of the Nervous System is crucial for advancing neuroscience research and developing effective treatments for neurological disorders.

Most cited protocols related to «Systems, Nervous»

Benchmarking was performed using the proteomes of five model species downloaded from eggNOG v.4.5 (Huerta-Cepas et al. 2016 (link)b), namely Escherichia coli (4,146 proteins), Drosophila melanogaster (13,937 proteins), Saccharomyces cerevisiae (5,429 proteins), Arabidopsis thaliana (28,128 proteins) and Homo sapiens (22,834 proteins). For all five proteomes, GO terms were retrieved from eggNOG version 4.5. GO terms with experimentally validated evidence codes (EXP, IDA, IPI, IMP, IGI, IEP) were considered curated positive terms. Similarly, any assignment of a term to a protein from a taxon it is excluded from (according to taxon exclusion data downloaded in December 2015 from the Gene Ontology Consortium) was considered a false positive (e.g., nervous system development terms assigned to a plant gene). Non-curated terms that are not explicitly listed in the false positive category were considered uncertain terms.
Full text: Click here
Publication 2017
Arabidopsis thalianas Drosophila melanogaster Escherichia coli Genes, Plant Homo sapiens Proteins Proteome Saccharomyces cerevisiae Staphylococcal Protein A Systems, Nervous
TRAP data were generated as described (1 (link),2 (link)), and are available for download from GEO: GSE13379. Etv1 data were not plotted because of known contamination with endothelial or lymphoblast cells (1 (link)). Other cell types and drivers are listed in Table 1. This dataset contains samples representing a variety of pure and mixed cell types from different structures of the mouse brain, as well as samples from the corresponding whole tissue. The purified samples are referred to as immunoprecipitates (IP). In parallel, RNA which did not bind to the antibody was also harvested to provide an assessment of the gene expression of the tissue as a whole. These samples are referred to as unbound RNA. Microarray analysis, as traditionally applied to the nervous system, results in samples that are most similar to unbound samples. As the immunoprecipitation does not lead to significant depletion of cell-specific RNAs, here we use the unbound samples as a measure for the total tissue homogenate RNA (referred to as Total).

List of the cell populations, relevant drivers and abbreviations

Cell populationsDriverAbbreviations used*
Drd1+ medium spiney neurons of neostriatumDrd1CS.Drd1
Drd2+ medium spiney neurons of neostriatumDrd2CS.Drd2
Cholinergic Interneurons of corpus striatumChatCS.Chat
Motor neurons of brain stemChatBS.Chat
Cholinergic neurons of basal forebrainChatBF.Chat
Mature oligodendrocytes of cerebellumCmtm5Cb.Cmtm5
Astroglia of cerebellumAldh1l1Cb.Aldh1L1
Golgi neurons of cerebellumGrm2Cb.Grm2
Unipolar brush cells and Bergman glia of cerebellumGrpCb.Grp
Stellate and basket cells of cerebellumLypd6Cb.Lypd6
Granule cells of cerebellumNeurod1Cb.Neurod1
Oligodendroglia of cerebellumOlig2Cb.Olig2
Purkinje cells of cerebellumPcp2Cb.Pcp2
Bergman glia and mature oligos. of cerebellumSept4Cb.Sept4
Cck+ neurons of cortexCckCtx.Cck
Mature oligodendrocytes of cortexCmtm5Ctx.Cmtm5
Cort+ interneurons of cortexCortCtx.Cort
Astrocytes of cortexAldh1l1Ctx.AldhL1
Corticospinal, corticopontine neuronsGlt25d2Ctx.Glt25d2
Corticothalamic neuronsNtsr1Ctx.Ntsr1
Oligodendroglia of cortexOlig2Ctx.Olig2
Pnoc+ neurons of cortexPnocCtx.Pnoc
Motor neurons of the spinal cordChatSC.Chat

*Abbreviations used for Figures 4, 5, 7 and Supplementary Figures 7 and 8

Publication 2010
2',5'-oligoadenylate Brain Cells DRD1 protein, human Endothelium Gene Expression Immunoglobulins Immunoprecipitation Interneurons Microarray Analysis Mus Neuroglia Neurons Oligodendroglia Population Group Systems, Nervous Tissues

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
ECHO protocol Epistropheus Ethics Committees, Research Head Human Body Males Mental Disorders MRI Scans Radionuclide Imaging Seahorses Systems, Nervous TRIO protein, human
This investigation was performed in the CPCCRN of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (8 (link)). Detailed methods for the TOPICC data collection have been previously described (6 (link)). There were seven sites, and one was composed of two institutions. In brief, patients from newborn to less than 18 years were randomly selected and stratified by hospital from December 4, 2011, to April 7, 2013. Patients from both general/medical and cardiac/cardiovascular PICUs were included. Moribund patients (vital signs incompatible with life for the first 2 hr after PICU admission) were excluded. Only the first PICU admission during hospitalization was included. The protocol was approved by all participating institutional review boards. Other analyses using this database have been published (6 (link), 7 (link), 9 (link), 10 (link)).
Data included descriptive and demographic information (Table 1). Interventions included both surgery and interventional catheterization. Cardiac arrest included closed chest massage within 24 hours before hospitalization or after hospital admission but before PICU admission. Admission source was classified as emergency department, inpatient unit, postintervention unit, or admission from another institution. Diagnosis was classified by the system of primary dysfunction based on the reason for PICU admission; cardiovascular conditions were classified as congenital or acquired.
The primary outcome in this analysis was hospital survival versus death.
Physiologic status was measured using the PRISM physiologic variables (5 (link)) with a shortened time interval (2 hr before PICU admission to 4 hr after admission for laboratory data and the first 4 hr of PICU care for other physiologic variables). For model building, the PRISM components were separated into cardiovascular (heart rate, systolic blood pressure, and temperature), neurologic (pupillary reactivity and mental status), respiratory (arterial Po2, pH, Pco2, and total bicarbonate), chemical (glucose, potassium, blood urea nitrogen, and creatinine), and hematologic (WBC count, platelet count, prothrombin, and partial thromboplastin time) components, and the total PRISM was also separated into neurologic and non-neurologic categories.
The time interval for assessing PRISM data was modified for cardiac patients under 91 days old because some institutions admit infants to the PICU before a cardiac intervention to “optimize” the clinical status but not for intensive care; in these cases, the postintervention period more accurately reflects intensive care. However, in other infants for whom the cardiac intervention is delayed after PICU admission or the intervention is a therapy required because of failed medical management of the acute condition, the routine PRISM data collection time interval is an appropriate reflection of critical illness. Therefore, we identified infants for whom it would be more appropriate to use data from the 4 hours after the cardiac intervention (postintervention time interval) and those for whom using the admission time interval was more appropriate. We operationalized this decision on the conditions likely to present within the first 90 days, the time period when the vast majority of these conditions present (Table 2).
Statistical analyses used SAS 9.4 (SAS Institute Inc., Cary, NC) for descriptive statistics, model development, and fit assessment and R 3.1.1 (The R Foundation for Statistical Computing, Vienna, Austria; http://www.wu.ac.at/statmath) for evaluation of predictive ability. Patient characteristics were descriptively compared and evaluated across sites using the Kruskal-Wallis test for continuous variables and the Pearson chi-square test for categorical variables. The statistical analysis was under the direction of R.H.
The dataset was randomly divided into a derivation set (75%) for model building and a validation set (25%) stratified by the study site. Univariate mortality odds ratios were computed, and variables with a significance level of less than 0.1 were considered candidate predictors for the final model. As was the case for the previously published trichotomous (death, survival with significant new morbidity, and intact survival) model construction, a nonautomated (examined by biostatistician and clinician at each step) backward stepwise selection approach was used to select factors. Multicategorical factors (e.g., diagnostic categories) had factors combined when appropriate per statistical and clinical criteria. Clinician input was included (and paramount) in this process to ensure that the model fit was relevant and consistent with clinical information. Construction of a clinically relevant, sufficiently predictive model using predictors readily available to the clinician took precedence over inclusion based solely on statistical significance. We were cognizant of the existing trichotomous outcome model and attempted, when statistically justified, to create a compatible two-outcome model that could aid in a smooth transition to using the three-outcome approach.
Final candidate models were evaluated based on 2D receiver operating characteristic (ROC) curves (discrimination) and the Hosmer-Lemeshow goodness of fit (calibration). For the entire dataset, goodness of fit with respect to key subgroups was assessed by examining SMRs for descriptive and diagnostic categories not used in the final model. Only categories with at least 10 outcomes in observed and expected cells were used.
Publication 2016
Activated Partial Thromboplastin Time Arteries Bicarbonates Cardiac Arrest Cardiovascular Diseases Cardiovascular System Catheterization Cells Chest Creatinine Critical Illness Diagnosis Discrimination, Psychology Disease Management Ethics Committees, Research Glucose Heart Hospitalization Infant Infant, Newborn Inpatient Intensive Care Massage Operative Surgical Procedures Patients physiology Platelet Counts, Blood Potassium prisma Prothrombin Rate, Heart Reflex Respiratory Diaphragm Respiratory Rate Signs, Vital Systems, Nervous Systolic Pressure Therapeutics Urea Nitrogen, Blood

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2007
Attention Brain Cloning Vectors fMRI Hemodynamics Nervousness Pneumogastric Nerve Systems, Nervous

Most recents protocols related to «Systems, Nervous»

Not available on PMC !

Example 9

In a preferred embodiment, endogenous cells are transfected with vectors such as those described herein in vivo by introduction of the therapeutic vector(s) into the host blood, tissues, nervous system, bone marrow, etc. The greatest benefit may be achieved by modifying a large number of endogenous target cells. This may be accomplished by using an appropriately-sized, catheter-like device, or needle to inject the therapeutic vector(s) into the venous or arterial circulation, into a specific tissue, such as muscle tissue, or into the nervous system. In a preferred embodiment, the virus is pseudotyped with VSV-G envelope glycoprotein and native HIV-1 env proteins.

Full text: Click here
Patent 2024
Arteries BLOOD Bone Marrow Catheters Cells Cloning Vectors Gene Products, env Genetic Vectors Glycoproteins HIV-1 Medical Devices Muscle Tissue Needles Systems, Nervous Therapeutics Tissues Veins Virus
This retrospective cohort study was approved by the Zhengzhou University Ethics Committee (2019-KY-018). All the patients submitted written informed consent for participation. We collected the clinical data of 228 patients in the Department of Neurology of the First Affiliated Hospital of Zhengzhou University from April 2014 to April 2021. All patients met the international diagnostic criteria of anti-NMDAR encephalitis (17 (link)), with at least one of the following symptoms: (1) psychiatric disturbance, seizures, abnormal movement, speech disorder, consciousness declination, and autonomic dysfunction/central hypoventilation; (2) CSF positive for anti-NMDAR antibodies; and (3) free of other diseases. The exclusion criteria were as follows: (1) anti-NMDAR encephalitis previously diagnosed and treated with corticosteroids, intravenous immunoglobulin, immunosuppressants, plasma exchange, and other immunotherapies in other medical institutions before admission (n = 16); (2) with another comorbid serious disease, such as tumor, recurrent serious infection, recent use of anticoagulants, or other conditions affecting the nervous system (n = 11 patients); and (3) patients with incomplete data (n = 20). The screening process is shown in Figure 1.
Full text: Click here
Publication 2023
Adrenal Cortex Hormones Anti-Antibodies Anti-N-Methyl-D-Aspartate Receptor Encephalitis Anticoagulants Autonomic Nervous System Disorders Consciousness Dyskinesias Ethics Committees Hypoventilation Immunosuppressive Agents Immunotherapy Intravenous Immunoglobulins N-Methyl-D-Aspartate Receptors Neoplasms Patients Plasmapheresis Seizures Speech Disorders Systems, Nervous
Twenty-four, male Tg mice (3–5 months old) expressing the HIV-1 tat (Tat+) or lacking the tat transgene (Tat−) were used for this study. Tg mice were generated and housed in an environmentally controlled vivarium (12 h light/dark cycle; lights off at 6 pm) at Virginia Commonwealth University. Food and water were provided ad libitum. Expression of Tat was targeted preferentially to the nervous system in Tg mice via a GFAP-driven, reverse tetracycline transactivator (rtTA or tetracycline-on promoter) that was activated with doxycycline (DOX)-containing mouse chow as previously described (Bruce-Keller et al., 2008 (link); Hauser et al., 2009 (link)). Tat− mice expressing the rtTA promoter served as controls. DOX-containing chow (6 g/kg; Harlan Laboratories, Madison, WI) was freely available to both Tat+   and Tat− mice for 8 weeks. All procedures were approved by the Virginia Commonwealth University Institutional Animal Care and Use Committee and conformed to the Guide for Care and Use of Laboratory Animals (National Research Council, Washington DC).
Publication 2023
Animals, Laboratory Doxycycline Food Glial Fibrillary Acidic Protein Institutional Animal Care and Use Committees Light Males Mice, Laboratory Systems, Nervous tat Genes Tetracycline Trans-Activators Transgenes
Deep neural network (DNN) is an established artificial neural network system. DNN can be used to train on complex data and foresee outcomes. Single hidden layers are present in the structure of simple neural networks, while many hidden layers are present in DNNs in addition to an input and output layer (Costache et al., 2020 (link)). In DNN, the feed-forward network is operated and analysed using the back-propagation function. The network is challenging to train due to the rising number of hidden layers and accompanying varying learning speeds (Tien Bui et al., 2020 (link)). Due to the existence of various hidden layers, DNN can tackle a variety of complex classification problems. The DNN algorithm is regarded as a more potent and effective one in neural network systems (Schmidhuber, 2015 (link)). We employed “h2o” package (Arora et al., 2015 ) to implement this method in R version 3.5.0.
The 0-9 levels of disease severity at an interval of 1 were used as response variable for the generation of regression models. At the same time, the ten classes of disease severity levels were used as dependent variables for the development of classification models. The calibration of all the machine learning models has been done using 2/3rd of the total 600 data set whereas the remaining 1/3rd of the data was used for validation purposes. The root mean square error (RMSE), coefficient of determination (R2), and residual prediction deviation (RPD) were used to evaluate the regression models’ accuracy.
Where Pi is the predicted value, Oi is the observed value and n is the number of samples.
Chang et al. (2001) (link) classified prediction accuracies into accurate (RPD > 2), moderate (1.4< RPD< 2), and poor (RPD< 1.4).
The assessment of classification accuracy of different techniques used for the classification was made through confusion or error matrix. The overall accuracy or total accuracy (Ta) was obtained by dividing the total number of correct predictions to the total number of tested predictions as suggested by Lillesand et al. (2000) , p. 724. Another coefficient that was estimated from the confusion matrix function was the Kappa coefficient (K) which denoted the degree to which the percentage correct estimations of a confusion matrix due to “genuine” agreement versus “chance” agreement was made. It ranged from 0 (worst) to 1 (best). The formulae of these parameters are (Hasmadi et al., 2009 ):
Where, xij = number of counts in the ijth cell of the confusion matrix, N = total number of counts in the confusion matrix, xi+ = marginal total of row i, and x+i = marginal total of column i.
Full text: Click here
Publication 2023
BAD protein, human Cytosol Operator, Genetic Plant Roots Systems, Nervous
Neural bypass systems have the ability to perform neural recordings, process data, and deliver neurostimulation. Neural recordings can have varying degrees of spatial and temporal resolution. In order of increasing spatial resolution, recording methods can include: EEG, which typically records on the order of 1,000,000 neurons; ECoG, which typically records on the order of 100,000 neurons; microelectrode arrays, which can record local field potentials from 10,000s of neurons or up to 100 individual neurons within 60 μm, and then single neuron recordings which have the highest spatial and temporal resolution of a single neuron [9 (link)–11 (link)]. One recording system is the Neuroport System which takes a sampling rate of 10 kHz [12 (link)]. Recording methods such as EEG are typically less invasive but carry lower spatial resolution than their more invasive counterparts, such as ECoG [13 (link)]. EEG also greatly varies in the number and location of electrodes, though the sensorimotor cortex has been the most common site of recording. An invasive electrode strategy with stereo encephalography (SEEG) to record fine movement signals in humans has recently been demonstrated and has been highlighted for its potential to provide recording information with low operative risk in a neural bypass [6 (link), 14 (link)]. Chronically implanted recording devices have been prone to signal decay over time due to factors such as gliosis, but multi-unit recording devices have been more resistant to such decay [15 (link)].
Full text: Click here
Publication 2023
Electrocorticography Gliosis Homo sapiens Medical Devices Microelectrodes Movement Nervousness Neurons Sensorimotor Cortex Systems, Nervous

Top products related to «Systems, Nervous»

Sourced in United States, United Kingdom, Germany, Canada, Japan, Sweden, Austria, Morocco, Switzerland, Australia, Belgium, Italy, Netherlands, China, France, Denmark, Norway, Hungary, Malaysia, Israel, Finland, Spain
MATLAB is a high-performance programming language and numerical computing environment used for scientific and engineering calculations, data analysis, and visualization. It provides a comprehensive set of tools for solving complex mathematical and computational problems.
Sourced in United States
The OmniPlex Neural Data Acquisition System is a hardware and software platform designed for recording and analyzing neural signals. It provides multi-channel data acquisition capabilities for capturing electrical activity from the nervous system.
Sourced in United States
The OmniPlex D Neural Data Acquisition System is a hardware and software platform designed for the acquisition and analysis of neural data. It provides the capability to record and process neural signals from multiple channels simultaneously.
Sourced in United States, Austria, Canada, Belgium, United Kingdom, Germany, China, Japan, Poland, Israel, Switzerland, New Zealand, Australia, Spain, Sweden
Prism 8 is a data analysis and graphing software developed by GraphPad. It is designed for researchers to visualize, analyze, and present scientific data.
Sourced in United States, United Kingdom
Offline Sorter is a software tool for offline analysis of electrophysiology data. It allows users to view, sort, and analyze recorded neural signals.
Sourced in United States, Austria, Japan, Belgium, United Kingdom, Cameroon, China, Denmark, Canada, Israel, New Caledonia, Germany, Poland, India, France, Ireland, Australia
SAS 9.4 is an integrated software suite for advanced analytics, data management, and business intelligence. It provides a comprehensive platform for data analysis, modeling, and reporting. SAS 9.4 offers a wide range of capabilities, including data manipulation, statistical analysis, predictive modeling, and visual data exploration.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States
The OmniPlex D is a multi-channel neurophysiology data acquisition system designed for recording and analyzing neural signals. It features high-quality signal amplification, digital filtering, and real-time data processing capabilities.
Sourced in Canada
The STEMdiff neural system is a laboratory equipment product that supports the differentiation of pluripotent stem cells into neural lineages. It provides a defined, serum-free culture system for the efficient generation of neural progenitor cells and mature neural cell types. The core function of this system is to facilitate the controlled, stepwise differentiation of stem cells towards specific neural cell fates.
Sourced in United States, Germany, United Kingdom, France, Canada
Rabbit anti-GFP is a polyclonal antibody raised against green fluorescent protein (GFP) in rabbits. This antibody can be used to detect and visualize GFP-tagged proteins in various experimental applications.

More about "Systems, Nervous"

The central nervous system (CNS) and peripheral nervous system (PNS) work together to coordinate the body's essential functions, from movement and sensation to cognition and emotion.
The CNS, comprising the brain and spinal cord, processes and transmits information, while the PNS, with its vast network of nerves, connects the CNS to the rest of the body.
Understanding this intricate neural network is crucial for advancing neuroscience research and developing effective treatments for neurological disorders.
Cutting-edge tools like the OmniPlex Neural Data Acquisition System and OmniPlex D Neural Data Acquisition System, along with powerful data analysis software like MATLAB, Prism 8, Offline Sorter, and SAS version 9.4, are revolutionizing the way researchers study the nervous system.
These innovative technologies enable researchers to record, process, and analyze neural signals with unprecedented precision, paving the way for groundbreaking discoveries.
Additionaly, the STEMdiff neural system and Rabbit anti-GFP antibodies provide researchers with valuable tools for studying neural development and the dynamics of neural networks.
By leveraging these advanced resources, neuroscientists can gain deeper insights into the complexities of the nervous system and explore new frontiers in the field.
Whether you're investigating the intricacies of neural signaling, exploring the role of the CNS and PNS in cognitive processes, or developing novel therapies for neurological disorders, the wealth of resources and technologies available today can help streamline your research and uncover innovative solutions.
Experience the future of neuroscience research with the power of these cutting-edge tools and techniques.